Podcast: Play in new window | Download (Duration: 58:58 — 53.0MB) | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Blubrry | Podcast Index | Email | TuneIn | RSS | More
This episode is a great update on Murat Tunaboylu, Antiverse and how ML/AI in biotech can change the world.
Similarly, startups are full of cliché’s, such as if you cannot finish a raise in 6 months that it wont happen. This episodes breaks those clichés a part and shows the truth that grit and perseverance can get you.
Murat has been on the show before when he was just coming out of Deep Science Ventures (Dominic Falcão) as well so it’s exciting to see what he has been up to for the last few years.
Links
https://www.antiverse.io/
https://www.linkedin.com/in/murattunaboylu/
https://www.linkedin.com/feed/update/urn:li:activity:6777607978867535872/
Antiverse:
“Co-founded in 2017 by engineers Murat Tunaboylu and Ben Holland, our team is dedicated to engineering the future of drug development to change the course of people’s lives. We are passionate about what we do and the impact our discoveries will have on patients across the globe. Based in Cardiff, our expert team spans structural biology, machine learning and medicine – and together, we are always striving for that next breakthrough in drug discovery.”
“Antiverse works alongside your expert lab scientists, using next-generation sequencing (NGS) to extract even more data from existing workloads. Our AI-Augmented Drug Discovery platform and trained models analyse the statistics gained from thousands of experiments. These are compared against known data to propose the best selection of candidates according to your criteria.”
Hiring, Distributed Team, venture capital, machine learning, learning software engineering, AI, biotech, stories